Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
3.295
-0.075 (-2.23%)
Apr 29, 2026, 11:37 AM EDT - Market open
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of $305.35 million as of April 29, 2026. Its market cap has decreased by -59.49% in one year.
Market Cap
305.35M
Enterprise Value
180.55M
1-Year Change
-59.49%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since October 28, 2015, Anavex Life Sciences's market cap has increased from $284.60M to $305.35M, an increase of 7.29%. That is a compound annual growth rate of 0.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 312.30M | -1.82% |
| Dec 31, 2025 | 318.10M | -65.08% |
| Dec 31, 2024 | 910.90M | 19.20% |
| Dec 29, 2023 | 764.20M | 5.86% |
| Dec 30, 2022 | 721.90M | -45.24% |
| Dec 31, 2021 | 1.32B | 264.55% |
| Dec 31, 2020 | 361.60M | 148.69% |
| Dec 31, 2019 | 145.40M | 100.00% |
| Dec 31, 2018 | 72.70M | -48.95% |
| Dec 29, 2017 | 142.40M | -9.24% |
| Dec 30, 2016 | 156.90M | -18.58% |
| Dec 31, 2015 | 192.70M | -32.29% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 325.27M |
| Cabaletta Bio | 323.95M |
| Compass Therapeutics | 322.36M |
| Inhibikase Therapeutics | 322.15M |
| NervGen Pharma | 311.58M |
| LENZ Therapeutics | 306.02M |
| Foghorn Therapeutics | 305.83M |
| Abeona Therapeutics | 303.75M |